Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECLIPSES: Dose adaptation of iron supplementation in pregnancy
2012-005480-28Phase 4Completed
- Sponsor
- IDIAPJGol
- Start
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of ferrimannitol ovalbumin in iron deficiency anemia (IDA) and anaemia (2 arms), sponsored by IDIAPJGol. Primary endpoint: Haemoglobin levels at end of gestation. Started Apr 2013; status: completed.
02
Drugs
ferrimannitol ovalbumin
03
Conditions
iron deficiency anemia (IDA)anaemia
Beyond the preview
Go deeper on 2012-005480-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005480-28.